Igor Puzanov, MD | Authors

Articles

T-VEC in Combination with Ipilmumab for Melanoma Treatment

August 30, 2014

Igor Puzanov, MD, medical oncologist, Vanderbilt-Ingram Cancer Center, discusses the rationale behind a phase Ib study to evaluate the efficacy and safety of T-VEC and ipilimumab in previously untreated, unresected stage IIIB-IV melanoma